This update includes:

  • DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months
  • FAQ – CMS Waivers, Flexibilities, and the End of the COVID-19 PHE
  • Fact Sheet – Telehealth Flexibilities and Resources and the COVID-19 Public Health Emergency
  • and notable research and news developments